The Company is a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses. The Company intends to identify a prospective target company and complete an initial business combination in the health care industry. Montes Archimedes is sponsored by Patient Square Capital LLC and led by Chairman, CEO and President, Jim Momtazee, and Chief Financial Officer, Maria Walker.
Company profile
Ticker
ROIV
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Latest filings (excl ownership)
15-12B
Securities registration termination
12 Oct 21
8-K
Entry into a Material Definitive Agreement
1 Oct 21
25-NSE
Exchange delisting
30 Sep 21
8-K
Submission of Matters to a Vote of Security Holders
29 Sep 21
425
Business combination disclosure
21 Sep 21
8-K
Other Events
21 Sep 21
10-Q
2021 Q2
Quarterly report
16 Aug 21
DEFM14A
Proxy related to merger
10 Aug 21
425
Business combination disclosure
2 Aug 21
8-K
Regulation FD Disclosure
2 Aug 21
Latest ownership filings
SC 13G/A
INTEGRATED CORE STRATEGIES (US) LLC
14 Feb 22
SC 13G/A
Patient Square Capital LLC
12 Oct 21
4
Change in insider ownership
4 Oct 21
4
Maria C Walker
4 Oct 21
4
Stephen N. Oesterle
4 Oct 21
4
JAMES C MOMTAZEE
4 Oct 21
4
George S Barrett
4 Oct 21
SC 13G
Beryl Capital Management LLC
27 Sep 21
SC 13G
CITADEL ADVISORS LLC
17 May 21
SC 13G
BlueCrest Capital Management Ltd
26 Feb 21
Financial summary
Quarter (USD) | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 20 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.17 mm | 1.17 mm | 1.17 mm | 1.17 mm | 1.17 mm | |
Cash burn (monthly) | 96.69 k | (no burn) | 8.79 mm | 640.17 k | 19.83 k | |
Cash used (since last report) | 3.26 mm | n/a | 296.22 mm | 21.56 mm | 668.10 k | |
Cash remaining | -2.08 mm | n/a | -295.04 mm | -20.39 mm | 505.20 k | |
Runway (months of cash) | -21.5 | n/a | -33.5 | -31.9 | 25.5 |
Institutional ownership, Q4 2021
0.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 62 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 34.07 mm |
Total shares | 3.35 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Integrated Core Strategies | 3.35 mm | $34.07 mm |